Ladenburg Thalmann Financial Services’s iShares US Pharmaceuticals ETF IHE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | $569K | Sell |
10,647
-2,826
| -21% | -$151K | ﹤0.01% | 1706 |
|
|
2019
Q3 | $629K | Buy |
13,473
+1,317
| +11% | +$61.5K | ﹤0.01% | 1577 |
|
|
2019
Q2 | $611K | Sell |
12,156
-330
| -3% | -$16.6K | ﹤0.01% | 1587 |
|
|
2019
Q1 | $641K | Sell |
12,486
-5,205
| -29% | -$267K | ﹤0.01% | 1493 |
|
|
2018
Q4 | $830K | Sell |
17,691
-8,742
| -33% | -$410K | 0.01% | 1167 |
|
|
2018
Q3 | $1.48M | Buy |
26,433
+14,760
| +126% | +$826K | 0.01% | 882 |
|
|
2018
Q2 | $574K | Hold |
11,673
| – | – | 0.01% | 1465 |
|
|
2018
Q1 | $574K | Sell |
11,673
-939
| -7% | -$46.2K | 0.01% | 1465 |
|
|
2017
Q4 | $649K | Buy |
12,612
+1,095
| +10% | +$56.3K | 0.01% | 1354 |
|
|
2017
Q3 | $599K | Buy |
11,517
+804
| +8% | +$41.8K | 0.01% | 1334 |
|
|
2017
Q2 | $552K | Sell |
10,713
-279
| -3% | -$14.4K | 0.01% | 1324 |
|
|
2017
Q1 | $548K | Sell |
10,992
-684
| -6% | -$34.1K | 0.01% | 1276 |
|
|
2016
Q4 | $549K | Buy |
11,676
+318
| +3% | +$15K | 0.01% | 1200 |
|
|
2016
Q3 | $566K | Sell |
11,358
-5,517
| -33% | -$275K | 0.01% | 1118 |
|
|
2016
Q2 | $813K | Sell |
16,875
-609
| -3% | -$29.3K | 0.01% | 852 |
|
|
2016
Q1 | $798K | Buy |
17,484
+4,545
| +35% | +$207K | 0.01% | 797 |
|
|
2015
Q4 | $697K | Sell |
12,939
-48,378
| -79% | -$2.61M | 0.01% | 848 |
|
|
2015
Q3 | $3.03M | Sell |
61,317
-6,609
| -10% | -$326K | 0.06% | 290 |
|
|
2015
Q2 | $3.96M | Buy |
67,926
+32,100
| +90% | +$1.87M | 0.07% | 263 |
|
|
2015
Q1 | $2.06M | Buy |
35,826
+20,754
| +138% | +$1.19M | 0.04% | 416 |
|
|
2014
Q4 | $761K | Buy |
15,072
+7,881
| +110% | +$398K | 0.02% | 712 |
|
|
2014
Q3 | $336K | Sell |
7,191
-1,416
| -16% | -$66.2K | 0.01% | 969 |
|
|
2014
Q2 | $388K | Buy |
8,607
+651
| +8% | +$29.3K | 0.01% | 877 |
|
|
2014
Q1 | $336K | Buy |
7,956
+2,622
| +49% | +$111K | 0.01% | 886 |
|
|
2013
Q4 | $210K | Buy |
5,334
+741
| +16% | +$29.2K | 0.01% | 1053 |
|
|
2013
Q3 | $163K | Buy |
4,593
+747
| +19% | +$26.5K | 0.01% | 1103 |
|
|
2013
Q2 | $128K | Buy |
+3,846
| New | +$128K | ﹤0.01% | 1185 |
|